volume 105, issue 1, PE349 2019
DOI: 10.1016/j.ijrobp.2019.06.1669
View full text
|
|
Share

Abstract: 30%, gr 3 in 30%, and unknown in 1%. LVSI was present in 73 patients (32%). Some patients with high risk histology underwent adjuvant chemotherapy (22%). Acute and chronic toxicity data was available for 190 and 158 patients, respectively. Table 1 lists common toxicities. The most common gr 1 acute toxicities were fatigue (11%), frequency (12%), and vaginal discharge (10%). All others were < 10%. The most common gr 1 chronic toxicities were frequency (13%), incontinence (12%), and vaginal stenosis (18%). All o…

expand abstract